Synopsys is one year past the Ansys close and the investment debate has shifted from whether regulators allow the combination to whether silicon-to-systems actually earns the purchase price. Management framed the third quarter as proof of focus and momentum. Revenue of $2,477 million cleared the high end of the company's own range. That print still mixes a full Ansys contribution against a year-ago stub, so the headline growth rate is not the organic story. The organic question is whether electronic design automation, the software engineers use to design chips, can accelerate from high-single-digit growth into a double-digit year.
The tension sits in the gap between adjusted profitability and reported earnings. Non-GAAP operating margin reached 42 percent as Ansys cost cuts ran ahead of the close-date plan. Design IP, the pre-built circuit blocks sold into larger chips, returned to year-over-year growth after two declining quarters. GAAP results still lean on a large gain from selling the processor IP line to GlobalFoundries. Nine-month reported net income is still below the prior year because amortization and a larger restructuring program continue to dominate the income statement. Cash is the cleaner read. Free cash flow in the quarter was $746 million. The company lifted the full-year cash target by $600 million.
The next several months resolve whether this is a durable operating company or a still-digesting deal. Management expects electronic design automation growth to reach double digits in the fourth quarter and for the full fiscal year. The first joint product, Multiphysics Fusion, is not slated to add to that growth until the following fiscal year. Investor Day at the end of September is where Factory Two royalty economics and agentic-AI pricing are supposed to become measurable. Shares near $385 sit well below the year high even after the post-print bounce. That price is the market asking whether the cash raise is enough to offset dilution, China, and a delayed product clock.